Skip to content

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02938611
Acronym
MRC-Gard
Enrollment
3375
Registered
2016-10-19
Start date
2019-01-01
Completion date
2025-12-31
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Brief summary

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* chronic kidney disease (stage \>= 4)

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (raw number)from baseline (day 0) to 12 months
The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (%)from baseline (day 0) to 12 months

Secondary

MeasureTime frame
The percentage of patients with CKD stage >= 4 correctly reported by participating nephrologistsfrom baseline (day 0) to 12 months
For each nephrologist participating in the study, the % of patients with stage >=4 chronic kidney disease who are correctly declaredfrom baseline (day 0) to 12 months
The % of patients with chronic kidney disease stage > = 4 in the Gard according to laboratory data and who are not seen by a nephrologistfrom baseline (day 0) to 12 months

Countries

France

Contacts

Primary ContactOlivier Moranne, MD, PhD
olivier.moranne@chu-nimes.fr+33.(0)4.66.68.31.49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026